These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38844774)

  • 1. Genomic profiles of Japanese patients with vulvar squamous cell carcinoma.
    Fujii E; Kato MK; Yamaguchi M; Higuchi D; Koyama T; Komatsu M; Hamamoto R; Ishikawa M; Kato T; Kohno T; Shiraishi K; Yoshida H
    Sci Rep; 2024 Jun; 14(1):13058. PubMed ID: 38844774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular events in the pathogenesis of vulvar squamous cell carcinoma.
    Xing D; Fadare O
    Semin Diagn Pathol; 2021 Jan; 38(1):50-61. PubMed ID: 33032902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
    Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ
    Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
    Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
    Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA.
    Watkins JC; Howitt BE; Horowitz NS; Ritterhouse LL; Dong F; MacConaill LE; Garcia E; Lindeman NI; Lee LJ; Berkowitz RS; Nucci MR; Crum CP
    Mod Pathol; 2017 Mar; 30(3):448-458. PubMed ID: 27834349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent genetic alterations and biomarker expression in primary and metastatic squamous cell carcinomas of the vulva.
    Xing D; Liu Y; Park HJ; Baek I; Tran H; Cheang G; Novo J; Dillon J; Matoso A; Farmer E; Cheng MA; Tsai YC; Lombardo K; Conner MG; Vang R; Hung CF; Wu TC; Song W
    Hum Pathol; 2019 Oct; 92():67-80. PubMed ID: 31437519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
    Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
    Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
    [No Abstract]   [Full Text] [Related]  

  • 9. Genomic characterization of vulvar squamous cell carcinoma.
    Prieske K; Alawi M; Oliveira-Ferrer L; Jaeger A; Eylmann K; Burandt E; Schmalfeldt B; Joosse SA; Woelber L
    Gynecol Oncol; 2020 Sep; 158(3):547-554. PubMed ID: 32591094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular targets in vulvar cancers.
    Palisoul ML; Mullen MM; Feldman R; Thaker PH
    Gynecol Oncol; 2017 Aug; 146(2):305-313. PubMed ID: 28536037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Landscape of Vulvar Squamous Cell Carcinoma.
    Carreras-Dieguez N; Guerrero J; Rodrigo-Calvo MT; Ribera-Cortada I; Trias I; Jares P; López Del Campo R; Saco A; Munmany M; Marimon L; Ferrando M; Vega N; Del Pino M; Torné A; Ordi J; Rakislova N
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
    Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.
    Tessier-Cloutier B; Kortekaas KE; Thompson E; Pors J; Chen J; Ho J; Prentice LM; McConechy MK; Chow C; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Bosse T; Hoang LN
    Mod Pathol; 2020 Aug; 33(8):1595-1605. PubMed ID: 32203095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.
    Lérias S; Esteves S; Silva F; Cunha M; Cochicho D; Martins L; Félix A
    Mod Pathol; 2020 May; 33(5):893-904. PubMed ID: 31844270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
    Yang H; Almadani N; Thompson EF; Tessier-Cloutier B; Chen J; Ho J; Senz J; McConechy MK; Chow C; Ta M; Cheng A; Karnezis A; Huvila J; McAlpine JN; Gilks B; Jamieson A; Hoang LN
    Mod Pathol; 2023 Jun; 36(6):100145. PubMed ID: 36828360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.